My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 170

    1.

    Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital.

    Maisel WH, Kuntz KM, Reimold SC, Lee TH, Antman EM, Friedman PL, Stevenson WG.

    Ann Intern Med. 1997 Aug 15;127(4):281-4.PMID: 9265427 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

    Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.

    Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. Review.PMID: 12670638 [PubMed - indexed for MEDLINE]Related articles

    3.

    Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.

    Chung MK, Schweikert RA, Wilkoff BL, Niebauer MJ, Pinski SL, Trohman RG, Kidwell GA, Jaeger FJ, Morant VA, Miller DP, Tchou PJ.

    J Am Coll Cardiol. 1998 Jul;32(1):169-76.PMID: 9669266 [PubMed - indexed for MEDLINE]Related articles

    4.

    Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.

    Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM.

    Card Electrophysiol Rev. 2003 Sep;7(3):201-7. Review.PMID: 14739713 [PubMed - indexed for MEDLINE]Related articles

    5.

    Atrial fibrillation: rate control often better than rhythm control.

    [No authors listed]

    Prescrire Int. 2004 Apr;13(70):64-9.PMID: 15148984 [PubMed - indexed for MEDLINE]Related articles

    6.

    Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.

    Deneer VH, Borgh MB, Kingma JH, Lie-A-Huen L, Brouwers JR.

    Pharm World Sci. 2004 Apr;26(2):66-78. Review.PMID: 15085940 [PubMed - indexed for MEDLINE]Related articles

    7.

    Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter.

    Hauser TH, Pinto DS, Josephson ME, Zimetbaum P.

    Am J Cardiol. 2003 Jun 15;91(12):1437-41.PMID: 12804730 [PubMed - indexed for MEDLINE]Related articles

    8.

    Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter.

    Reithmann C, Dorwarth U, Dugas M, Hahnefeld A, Ramamurthy S, Remp T, Steinbeck G, Hoffmann E.

    Eur Heart J. 2003 Jul;24(13):1264-72.PMID: 12831821 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.

    Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM; GUSTO-III Investigators.

    Heart. 2002 Oct;88(4):357-62.PMID: 12231591 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Arrhythmias in the intensive care patient.

    Trappe HJ, Brandts B, Weismueller P.

    Curr Opin Crit Care. 2003 Oct;9(5):345-55. Review.PMID: 14508146 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

    Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG.

    J Am Coll Cardiol. 1992 Sep;20(3):527-32.PMID: 1512329 [PubMed - indexed for MEDLINE]Related articles

    12.

    Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.

    Middlekauff HR, Stevenson WG, Gornbein JA.

    Arch Intern Med. 1995 May 8;155(9):913-20.PMID: 7726699 [PubMed - indexed for MEDLINE]Related articles

    13.

    Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.

    Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A.

    Heart. 2002 May;87(5):443-8.PMID: 11997417 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

    Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

    Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.PMID: 18547499 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation]

    Kosior D, Szulc M, Zawadzka M, Pierścińska M, Stawicki S, Rabczenko D, Torbicki A, Opolski G.

    Pol Arch Med Wewn. 2002 Dec;108(6):1151-60. Polish. PMID: 12687927 [PubMed - indexed for MEDLINE]Related articles

    16.

    Avoiding drug problems. The safety of drugs for supraventricular tachycardia.

    Reimold SC.

    Eur Heart J. 1997 May;18 Suppl C:C40-4. Review.PMID: 9152674 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.

    Tuinenburg AE, Van Gelder IC, Van Den Berg MP, Brügemann J, De Kam PJ, Crijns HJ.

    Heart. 1999 Oct;82(4):486-93.PMID: 10490566 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.

    Joseph AP, Ward MR.

    Ann Emerg Med. 2000 Jul;36(1):1-9.PMID: 10874228 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study]

    Fetsch T, Burschel G, Breithardt G, Engberding R, Koch HP, Lukl J, Trappe HJ, Treese N.

    Z Kardiol. 1999 Mar;88(3):195-207. German. PMID: 10355070 [PubMed - indexed for MEDLINE]Related articles

    20.

    Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.

    Lafuente-Lafuente C, Mouly S, Longás-Tejero MA, Mahé I, Bergmann JF.

    Arch Intern Med. 2006 Apr 10;166(7):719-28. Review.PMID: 16606807 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity